| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $854K | -9.1% | +277.4% |
| Cost of Revenue | $592K | +12.1% | +392.6% |
| Gross Profit | $262K | -36.4% | +146.8% |
| R&D Expense | $739K | -1.2% | +128.4% |
| SG&A Expense | $1.1M | +46.9% | +357.4% |
| Operating Income | -$2.4M | -23.3% | -274.9% |
| Interest Expense | $821K | +19.2% | +54.9% |
| Pre-tax Income | -$3.2M | -22.2% | -173.6% |
| Net Income | -$3.3M | -21.8% | -34.4% |
| EPS (Basic) | -$0.04 | +0.0% | -33.3% |
| EPS (Diluted) | -$0.04 | +0.0% | -33.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $632K | +351.3% | +441.4% |
| Current Assets | $2.6M | +206.1% | +88.8% |
| Total Assets | $3.0M | +126.4% | +46.0% |
| Current Liabilities | $10.1M | +9.2% | +25.4% |
| Long-term Debt | $21.5M | +26.6% | +78.1% |
| Total Liabilities | $27.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.0M | — | — |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | -$2K | — | — |
| Financing Cash Flow | $6.4M | — | — |
| Free Cash Flow | -$6.0M | — | — |
| +62.0% |
| Stockholders' Equity | -$24.1M | -13.3% | -64.2% |